Park Square is pleased to announce the placement of Gavin MacBeath as Chief Scientific Officer at TScan Therapeutics, Inc. TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system.

MacBeath most recently served as the Chief Scientific Officer at Abpro Corporation. Previously, MacBeath held various roles at Merrimack Pharmaceuticals, Inc., including Founder and Senior Vice President, Discovery; Vice President, Translational Research; and Senior Director and Head, Translational Research. Earlier, he held various roles at Harvard University, including Associate Professor, Department of Chemistry and Chemical Biology; Assistant Professor, Department of Chemistry and Chemical Biology; and Research Fellow and PI, Bauer Center for Genomics Research. 

MacBeath received his B.S. from University of Manitoba and his Ph.D. from The Scripps Research Institute. 

Park Square Executive Search serves companies and institutions that are shaping the world through discovery, innovation and growth. Our clients are leading life sciences and healthcare organizations, technology companies, major research universities, and venture capital and private equity firms, including their portfolio companies. We place board members, chief executive officers, C-suite executives, and academic leaders.